Telehealth & OEM

Remote patient monitoring devices in the palm of your hand. Supporting Telemedicine & Telehealth providers’ digital healthcare platforms.

Respiratory monitoring, spirometry and ECG devices suitable for chronic conditions such as asthma, COPD, cystic fibrosis, ILD, post-transplant patients or any other respiratory monitoring. API developer’s kit and integration support via dedicated support team.

Fast and Accurate Lung Function Monitoring & Testing, Anytime, Anywhere.

  • The 12-lead ECG by Vitalograph enables full 12-lead electrocardiography with very low occurrence of lead artefact. Analysis and interpretation come as standard using the world class University of Glasgow interpretation algorithm which provides detailed diagnostic suggestions and evaluation of results. ECG measurements are captured and transmitted wirelessly for display in real-time and data is automatically saved for recall, reporting or printing. Transmitting ECG traces wirelessly is fast and safe with no leads to trip over or create artefacts from movement or electrical sources. The built-in display provides information on electrode contact problems, heart rate, battery status, communication status and digital pacemaker detection.
  • For effective inhaler training on dry powder and metered dose inhalers The unique Vitalograph AIM™ (Aerosol Inhalation Monitor) is designed to assist medical practitioners in assessing inhaler use, whether MDI or DPI. Mastery of the correct technique will support more accurate drug delivery and good patient compliance, resulting in better disease management and fewer visits to medical professionals.

  • Vitalograph ALPHA Touch is an easy to use, lightweight desktop spirometer that offers the benefits of portability and a built-in printer. The precise and durable measurement technology is extremely accurate and stable over time, assured through our simple calibration check routines as recommended by international spirometry guidelines (ARTP, ATS/ERS, etc.) and good practice. No need for expensive disposable sensors, turbine, spirettes nor flow tubes with optimal hygiene assured via Vitalograph Bacterial Viral Filters (BVF™). A large, high resolution colour touch screen display, combined with an intuitive icon driven user interface, makes the ALPHA Touch quick and simple to operate. A database for over 10,000 patients, child friendly incentive animations and the latest GLI spirometry predicted equations and Z-scores contribute to all round suitability for adult and paediatric patients within general healthcare and occupational health environments. The ALPHA Touch is supplied with Vitalograph Reports Software with the ability to create editable PDFs for filing and manual upload to electronic medical record (EMR) systems. Customers can also choose to upgrade to the ALPHA Touch with Spirotrac® Software, which allows for automatic data exchange, via HL7 and GDT transfer protocols, with EMR systems and the ability to add other diagnostic tests and physiological measurements (including resting 12-lead ECG, SpO2, NIBP and Audiometry).
  • The Vitalograph asma-1™ is a simple home use electronic respiratory monitor that measures PEF and FEV1 and may be integrated with smart phone or tablet for ePRO data collection. It offers greater accuracy than mechanical peak flow meters and eliminates the need for paper record cards.

  • Asma-BT

    For the home monitoring of asthma with electronic & hard copy reports The asma-1™ bt combines all of the features of the asma-1 with the ability to transmit results via Bluetooth using a paired device such as a mobile phone, PDA, PC or home hub. Session data and device ID may be transmitted to Vitalograph Reports, Spirotrac or an API developers' kit is available for providers of e-Diary, home hub and telemedicine solutions.

  • Electronic Asthma Monitor The Vitalograph asma-1™ child version is a simple to use electronic peak flow meter that measures PEF, FEV0.5, FEV0.75 and FEV1. It offers greater accuracy than mechanical peak flow meters and eliminates the need for paper record cards.

  • The asma-1™ USB combines all the features of the asma-1 with the ability to link to your PC. Session data and device ID may be transmitted to Vitalograph Reports, Spirotrac or an API developers' kit is available for providers of e-Diary, home hub and telemedicine solutions.

  • asmaPLAN & asmaPLAN+ The simple, accurate way to monitor asthma The patented dual color sliders on the asmaPLAN+™ define the management color zones set by the healthcare professional for the asthmatic to follow. 100% is the asthmatic's best. The yellow zone will typically be set to start at 80% of the asthmatic's best while the red zone will typically start at 60%. Variability of PEFR of greater than 20% should alert the asthmatic to a possible asthma attack.
  • Bacterial Viral Filters For effective infection control Unlike barrier filters that trap expectorated matter whilst allowing viruses and bacteria to pass through, Vitalograph filters use an electrostatically charged material that traps expectorated matter plus bacteria and viruses for highly effective protection against cross-contamination.

    In addition to the hygiene benefits of using bacterial viral filters, they also support productivity in pulmonary function testing by reducing the time spent cleaning and sterilizing test equipment.
  • Bite-on and Oval Mouthpieces Designed for comfort and performance These ergonomically designed mouthpieces offer a choice of fit for adults and children.

  • The Vitalograph COMPACT™ Expert is a medical workstation, with the ability to integrate market leading Vitalograph spirometry, with 12-lead ECG, pulse oximetry, COPD assessment, blood pressure measurement, challenge testing and more in a flexible, portable desktop solution. COMPACT features secure data management using data encryption in SQL databases, and the ability to exchange patient data with Electronic Medical Record (EMR) systems, using GDT & HL7 protocols.

  • For simple, fast & accurate COPD screening The copd-6™ identifies those at risk of COPD at the pre-symptomatic stage to allow early medical intervention and facilitate better clinical outcomes.

    This pioneering device screens out those whose FEV1 is normal and who, therefore, do not have COPD without the risk of false COPD negatives, allowing spirometry resources to be focused on those most at risk.

Title

Go to Top